Efficacy and safety of Wanfeile in the treatment of erectile dysfunction: Report of 100 cases and review of the literature.
- Author:
Wen-Jun CHEN
1
;
Jing CAO
1
;
Xuan-Wen ZHU
2
;
Zhen SUN
3
;
Qiang FU
4
;
Xiao-Lin LIU
5
Author Information
1. Department of Urology, Hangzhou Hospital of Zhejiang Corps of Armed Police Forces, Hangzhou, Zhejiang 310051, China.
2. .
3. Department of Urology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
4. Department of Urology, Hangzhou Renyu Maternity Hospital, Hangzhou, Zhejiang 310009, China.
5. Department of Urology, Hangzhou Qiangsheng Hospital, Hangzhou, Zhejiang 310006, China.
- Publication Type:Journal Article
- MeSH:
Double-Blind Method;
Drug Administration Schedule;
Erectile Dysfunction;
drug therapy;
Humans;
Male;
Phosphodiesterase 5 Inhibitors;
administration & dosage;
adverse effects;
Sildenafil Citrate;
administration & dosage;
adverse effects;
Surveys and Questionnaires;
Treatment Outcome
- From:
National Journal of Andrology
2017;23(5):448-451
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical effect and safety of Wanfeile in the treatment of erectile dysfunction (ED).
METHODS:Totally 100 ED patients received oral Wanfeile at 100 mg, once every 3 days, for a course of 3 months. We compared the IIEF-5 scores of the patients before and after medication and among the patients with different degrees of ED. We evaluated the total clinical effectiveness of Wanfeile and analyzed adverse reactions.
RESULTS:The total effectiveness rate of Wanfeile was 95.6%. All the patients showed significant improvement in the IIEF-5 scores after treatment as compared with the baseline (P <0.05). Adverse reactions were observed in 5 cases (5.50%), all mild and transient.
CONCLUSIONS:Wanfeile is safe and efficacious for the treatment of ED.
